OEP News
Press Release 14 Sep. 2023
In Alliance with B.L.HUA, Orient PHARMA’s New ADHD Durg Enters Thailand to Expand Southeast Asia Market
MORE
Media Reports 26 Jun. 2023
Getting out from The Bottom, OEP Is Optimistic about Profit This Year
MORE
Press Release 27 Jul. 2023
OEP’s Cytotoxic Oncology Injection Plant Completed US FDA Inspection
MORE
Explore OEP
About OEP
Built on understanding and meeting the real needs of people,
OEP is aim to become a benchmark enterprise in the Asia Pacific
Careers
Sincerely invite you to join OEP
Business Development
Continues to introduce a diverse range of innovative products and
expanding its overseas markets
Investors
Monthly Revenues 2023 August
CSR
OEP hopes to create a better society through continuous efforts and innovation
OEP Subsidiaries
Orient PHARMA, OP NanoPharma &
OEP Innovations
Overseas Business
To follow the trend of internationalization, Orient EuroPharma started to expand the foreign market in 1993 by establishing subsidiaries in Southeast Asia and moved into the Mainland China market with a complete marketing network.
